Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Nyxoah Plans $70M+ IPO As It Starts IDE Trial For Neurostim Apnea Device

Aug 27 2020

• By Phil Greenfield

IPO_Graph — • Source: Shutterstock

Related Content

ResMed Jumps On Board As Nyxoah Raises €25m For Neurostim Apnea Device

Feb 13 2020

IPOs Are Back: Liquid Biopsy, Cardio, Dialysis Firms Lead $1.5Bn Charge

Aug 25 2020

Related Companies

Nyxoah S.A.

ResMed, Inc.

Inspire Medical Systems, Inc.

Additional Topics

Financing Companies Commercial Neurology Medical Device

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window